Pages that link to "Item:Q3303685"
From MaRDI portal
The following pages link to Continual reassessment method with multiple toxicity constraints (Q3303685):
Displaying 10 items.
- Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer (Q70258) (← links)
- On the consistency of the continual reassessment method with multiple toxicity constraints (Q499432) (← links)
- A phase I dose-finding study based on polychotomous toxicity responses (Q1708945) (← links)
- Time-to-event continual reassessment method incorporating treatment cycle information with application to an oncology phase I trial (Q2931051) (← links)
- Designs foe phase i cancer clinical trials with differentiation of graded toxicity (Q4548226) (← links)
- A continual reassessment method without undue risk of toxicity (Q6171847) (← links)
- A generalized calibrated Bayesian hierarchical modeling approach to basket trials with multiple endpoints (Q6625443) (← links)
- Incorporating patient-reported outcomes in dose-finding clinical trials (Q6627303) (← links)
- Bayesian modeling of a bivariate toxicity outcome for early phase oncology trials evaluating dose regimens (Q6628011) (← links)
- Application of the patient-reported outcomes continual reassessment method to a phase I study of radiotherapy in endometrial cancer (Q6636217) (← links)
